Clinical Trial Update: Dose Finding Study to Evaluate Safety and Efficacy of 3 Dosages of SAP 001. [Phase 2]

View source ↗

Summary

A Phase 2 dose-finding clinical trial assessing three dosages of SAP 001 for gout; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout

Drugs mentioned

• SAP-001

Snippet

Sponsor: Shanton Pharma Pte. Ltd. | Conditions: Gout | Phase 2 | Status: ACTIVE_NOT_RECRUITING